Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA, Drug Administration

Digest more
 · 2d
FDA wants to limit compounded versions of weight loss drugs
The U.S. Food and Drug Administration on Thursday proposed excluding Novo Nordisk and Eli Lilly’s ‌weight-loss drugs from a key compounding list, potentially limiting large-scale production by outsour...

Continue reading

 · 2d · on MSN
FDA proposes curbs on mass copycats of Novo, Lilly's weight-loss drugs
 · 2d
US FDA Proposes Excluding Weight-Loss Drugs From Compounding List

FDA, pancreatic cancer and expanded access

Digest more
Top News
Overview
 · 1d
FDA expands access to pancreatic cancer drug helping patients like Ben Sasse
The Food and Drug Administration said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved for use.

Continue reading

 · 1d · on MSN
FDA green lights early access to pancreatic cancer drug, daraxonrasib
 · 1d
FDA expands access to a promising drug for one of the worst cancers
 · 1d
For pancreatic cancer, the FDA grants early access to the experimental drug daraxonrasib
Former U.S. Sen. Ben Sasse, R-Neb., is among those already being treated with the experimental pancreatic cancer drug.

Continue reading

 · 1d
FDA expands access to drug helping pancreatic cancer patients
 · 1d
Revolution Medicines' Pancreatic-Cancer Drug Cleared for Expanded Access
1d

AstraZeneca stock falls after FDA panel votes against new cancer drug

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
The Daily Signal
1h

Senate Report: Biden FDA ‘Ignored’ Early COVID-19 Vaccine Safety Warnings

A Senate report alleges that Biden administration health officials failed to act on early warning signs of potential COVID-19 vaccine side effects identified by a Food and Drug Administration scientist.
10hon MSN

Is Regeneron a Buy After the FDA Approved its Gene Therapy to Restore Hearing?

Regeneron is seeing double-digit revenue growth and has more than 50 therapies in its pipeline, making it a good long-term investment.
8h

Supreme Court asked to keep abortion drug mifepristone available by mail

Multiple GOP-led states are trying to make it harder for women to access mifepristone, a pill used in nearly two-thirds of abortions across the U.S.
1don MSN

Appeals court blocks FDA rule that allows women to obtain abortion drugs by mail

A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, undermining access to the method of abortion that has only grown more widespread since the US Supreme Court overturned Roe v.
20h

New FDA analysis says US infant formula supply is safe after testing for potential contaminants

A new analysis of chemicals in U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants, federal health officials said Wednesday. The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project — billed as the “largest and most rigorous” to date.
  • Privacy
  • Terms